P Cristofori
Overview
Explore the profile of P Cristofori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giantin M, Vascellari M, Lopparelli R, Ariani P, Vercelli A, Morello E, et al.
Res Vet Sci
. 2012 Aug;
94(1):90-9.
PMID: 22925934
In humans, the aryl hydrocarbon receptor (AHR) gene battery constitutes a set of contaminant-responsive genes, which have been recently shown to be involved in the regulation of several patho-physiological conditions,...
2.
Casartelli A, Bonato M, Cristofori P, Crivellente F, Dal Negro G, Masotto I, et al.
Cell Biol Toxicol
. 2003 Aug;
19(3):161-76.
PMID: 12945744
Phospholipidosis is a term commonly used to indicate a phospholipid storage disorder; in affected cells, phospholipids accumulate in lysosomes that acquire a multilamellar morphological appearance. Cationic amphiphilic drugs (CADs) are...
3.
Sorio C, Bonora A, Orlandini S, Moore P, Capelli P, Cristofori P, et al.
Virchows Arch
. 2001 Mar;
438(2):154-8.
PMID: 11253117
In order to assess the suitability of cryopreserved neoplastic tissues for xenografting into nude (nu/nu) mice, we compared the take rate in 28 samples of pancreatic ductal carcinoma. Eleven fresh...
4.
Cristofori P, Lanzoni A, Quartaroli M, Pastorino A, Zancanaro C, Cominacini L, et al.
J Hypertens
. 2000 Nov;
18(10):1429-36.
PMID: 11057430
Background: Lacidipine is a widely used calcium-channel blocker, which has both long-lasting antihypertensive activity and also antioxidant properties. Previous studies have demonstrated the ability of lacidipine to reduce the development...
5.
Cristofori P, Lanzoni A, Gaviraghi G, Turton J, Sbarbati A
Biomed Pharmacother
. 2000 Apr;
54(2):93-9.
PMID: 10759293
We have investigated the activity of the calcium antagonist lacidipine in male hamsters fed an atherogenic diet containing 2% cholesterol and 5% butter. Animals were examined at 14, 20 and...
6.
Marzola P, Nicolato E, Di Modugno E, Cristofori P, Lanzoni A, Ladel C, et al.
MAGMA
. 1999 Nov;
9(1-2):21-8.
PMID: 10555170
Although in vivo magnetic resonance imaging (MRI) is rapidly becoming a recognised tool in experimental pharmacological research, at the best of our knowledge, scarce application in the field of antibacterial...
7.
Trevisan A, Cristofori P, Fanelli G
Arch Toxicol
. 1999 Aug;
73(4-5):255-62.
PMID: 10463391
The possibility of detecting segment-specific injury of the proximal tubule by means of urinary enzymes was investigated in rats. Urinary glutamine synthetase, an enzyme exclusively localized in the S3 segment,...
8.
Trevisan A, Cristofori P, Fanelli G, Bicciato F, Stocco E
Arch Toxicol
. 1998 Oct;
72(8):531-5.
PMID: 9765069
Glutamine transaminase K(GTK) excretion assessed in urine and by kidney histology was evaluated in rats after single treatment with 1.0 mg/kg i.p. of mercuric chloride, 100 mg/kg i.p. of hexachloro-1:3-butadiene...
9.
Cristofori P, Sbarbati A, Accordini C, Terron A, Micheli D
J Submicrosc Cytol Pathol
. 1994 Jul;
26(3):331-40.
PMID: 8087797
We investigated the effect on cardiac hypertrophy of a once-daily treatment with lacidipine, at doses that do not reduce systolic blood pressure. Spontaneously hypertensive stroke-prone rats (SHR-SP) were fed a...
10.
Cristofori P, Micheli D, Terron A, Gaviraghi G
J Cardiovasc Pharmacol
. 1994 Jan;
23 Suppl 5:S90-3.
PMID: 7609515
Lacidipine is a second-generation 1,4-dihydropyridine calcium antagonist, whose potent and long-lasting antihypertensive properties prompted us to investigate whether its chronic administration to Dahl-S rats prevented salt-induced hypertension, vasculopathy, and accelerated...